Gorman-Rupp Company — 2014 Form 10-K
Reporting period: Fiscal year ended December 31, 2014. Gorman-Rupp designs, manufactures and sells pumps and pump systems globally, operating as one business segment.
Financial performance
| Metric | 2014 | 2013 | Change |
|---|---|---|---|
| Net sales | $434.9 million | $391.7 million | Up 11.0% |
| Income before income taxes | $53.7 million | $44.3 million | Up 21.4% |
| Total assets at year-end | $380.9 million | $355.6 million | Up 7.1% |
| Income before taxes as a share of sales | 12.4% | 11.3% | Up 1.1 percentage points |
Figures are rounded; changes and pretax margins are calculated from the filing’s reported amounts. The provided filing text does not give clear values for net income, cash flow, debt, or liquidity. Those financial statements are incorporated by reference from the shareholder annual report, but their details are not included in the supplied text.
Business changes and operating indicators
- International shipments were $136.6 million, or 31% of sales, versus $134.6 million, or 34%, in 2013. The company shipped to nearly 150 countries.
- Year-end backlog fell to $160.7 million from $182.2 million. The company attributed the decline to record shipments, including $11.7 million of shipments on the Permanent Canal Closures & Pumps flood-control project. About $43.2 million of that project remained in backlog.
- Approximately 95% of year-end backlog was scheduled for shipment during 2015, with most of the remainder scheduled for the first half of 2016.
- No single customer exceeded 10% of sales, and no foreign country accounted for more than 5% of sales in 2014, 2013, or 2012.
Outlook, risks and contingencies
- The filing text provides no specific financial guidance or quantified forecast. Management notes that pump-industry demand is cyclical and depends on customer capital spending and maintenance, credit availability, and broader industry and economic conditions.
- Commodity-price volatility, including oil and agricultural prices, may defer or cancel customer spending or orders. Raw-material and energy costs can fluctuate, and competitive conditions may limit the company’s ability to pass cost increases through to customers.
- Approximately 10% of revenue and certain costs, assets, and liabilities are denominated in foreign currencies, principally the Canadian dollar, euro, and South African rand. The company says historical exchange-rate changes have not materially affected its financial condition, results, or cash flows.
- The company cites import-export regulation, environmental compliance costs, and potential non-cash defined-benefit pension settlement expenses as risks. It says reasonably anticipated future environmental compliance spending is not expected to have a material adverse effect.
- The PCCP project is a fixed-price contract, with full government funding appropriated. Termination, cancellation, and delay provisions are governed by the Federal Acquisition Regulation.
- The company and a subsidiary remain involved in industry-wide asbestos litigation, often as co-defendants. Management does not currently believe these proceedings will materially affect results, liquidity, or financial condition; insurers have provided counsel, and some cases have been dismissed or nominally settled.
Important facts for investors to verify
- Review the incorporated financial statements and MD&A for net income, cash flow, debt, liquidity, and the drivers of revenue and earnings growth; these details are not present in the supplied filing text.
- Assess execution, costs, timing, and remaining obligations under the $43.2 million PCCP backlog, including the implications of its fixed-price terms.
- Evaluate whether the lower backlog and the 2015 shipment schedule translate into sustained sales and margins.
- Consider exposure to cyclical customer investment, input-cost changes, foreign currencies, pension settlement accounting, and asbestos litigation.
- Note that the filing reports effective disclosure controls as of December 31, 2014, no identified material weaknesses in internal control during 2014, and no material market-risk exposure required to be reported under Item 305.